Award

Using crystallography to answer questions of structure and function

Caroline Soliman wins JBC/Tabor Young Investigator Award
Kerri Beth  Boggs
March 1, 2019

Caroline Soliman discovered her love for lab work as an undergraduate studying biomedical science at Monash University in Melbourne, Australia. She thrived on doing hands-on work to answer the question “What’s my goal, and how am I going to get there?”

 

Caroline SolimanThe findings of Caroline Soliman’s team are crucial for understanding the function of carbohydrate-binding human antibodies as potential microbial therapeutics.

Now a graduate student at the Royal Melbourne Institute of Technology, or RMIT, Soliman won a 2019 Journal of Biological Chemistry/Herbert Tabor Young Investigator Award for her work on the structural characterization of antibody candidates that recognize carbohydrates for immunotherapy for infection.

Soliman earned an honors degree at Monash University through the Burnet Institute. For her thesis, she worked with Paul Ramsland, now her dissertation mentor, to develop a peptide-based inhibitor to mimic the binding of a microbial protein to immunoglobulin A. The project sparked an interest in crystallography.

“I gained an appreciation for the importance of structure in terms of function,” she said.

After a short break from research, Soliman returned to Ramsland’s lab for her doctoral training at RMIT. Together, they crafted a project with translational benefits and an international collaboration with Gerald Pier of Harvard Medical School that would give Soliman the chance to develop her crystallography skills.

“My supervisor has been very supportive and encouraging,” she said, adding that Ramsland helped her navigate the roadblocks of learning crystallography, teaching her how to collect data from the Australian Synchrotron and walking her through the process of solving a crystal structure.

When not solving crystal structures, Soliman can be found in the kitchen baking cakes, tarts and other sweet treats. She also enjoys reading, swimming at the beach and spending time with her family in Melbourne.

After completing her Ph.D., Soliman hopes to pursue a career in research and to teach immunology.

“It’s really important to do something you enjoy,” she said.

Fighting antibiotic resistance with antibodies

Antibiotics are used to fight bacterial infections, but antibiotic resistance has created a need for alternative therapies. Many of the antibiotic-resistant bacteria prioritized for therapeutic development are known to form biofilms, sticky aggregations of microbes that act as an additional barrier against antibacterial therapies.

Therapeutic antibodies are a strong candidate to overcome both antibiotic resistance and barriers such as bacterial biofilms. Humans typically develop protective antibodies to bacterial carbohydrates as a result of infection, so researchers have focused on carbohydrate-binding antibodies. Specifically, the human antibody F598 is being tested in the clinical setting because it can elicit protective activities after binding to the microbial carbohydrate poly-N-acetyl-D-glucosamine, or PNAG, which is a polymer of N-acetyl-D-glucosamine, or GlcNAc, units.

To understand how this antibody targets PNAG, Caroline Soliman and colleagues defined the structural basis for recognition of PNAG by F598. They determined crystal structures for the antibody-binding fragment, or Fab, of F598 and its complexes with two carbohydrates, GlcNAc and a PNAG oligosaccharide. They found that the Fab binds to extracellular polysaccharide in biofilms and to PNAG on the surface of Staphylococcus aureus.

This was the first study to report the structural basis for human antibody recognition of PNAG.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Kerri Beth  Boggs

Kerri Beth Boggs is a graduate student in the biochemistry department at the University of Kentucky.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Richard Silverman to speak at ASBMB 2025
ASBMB Annual Meeting

Richard Silverman to speak at ASBMB 2025

March 27, 2025

Richard Silverman and Melissa Moore are the featured speakers at the ASBMB annual meeting to be held April 12-15 in Chicago.

Women’s History Month: Educating and inspiring generations
Observance

Women’s History Month: Educating and inspiring generations

March 27, 2025

Through early classroom experiences, undergraduate education and advanced research training, women leaders are shaping a more inclusive and supportive scientific community.

ASBMB honors Lawrence Tabak with public service award
Award

ASBMB honors Lawrence Tabak with public service award

March 26, 2025

He will deliver prerecorded remarks at the 2025 ASBMB Annual Meeting in Chicago.

ASBMB names 2025 JBC/Tabor Award winners
Award

ASBMB names 2025 JBC/Tabor Award winners

March 24, 2025

The six awardees are first authors of outstanding papers published in 2024 in the Journal of Biological Chemistry.

Daniel N. Hebert (1962–2024)
Retrospective

Daniel N. Hebert (1962–2024)

March 17, 2025

Daniel Hebert’s colleagues remember the passionate glycobiologistscientist, caring mentor and kind friend.

In memoriam: Daniel N. Hebert
In Memoriam

In memoriam: Daniel N. Hebert

March 17, 2025

He was a professor at the University of Massachusetts Amherst, who discovered the glycan code that facilitates protein folding, maturation and quality control in the endoplasmic reticulum.